HLADRB30101 was the most associated allele, with reduced survival of patients with it. DRB50101 was another susceptibility allele and DRB40101 demonstrated a likely protective function.
Association with DRB11301, DQAI0103, and DQBI0603 haplotype was confirmed, whereas DRB104 was only slightly underrepresented. No difference was observed in age, presentation, liver function, histological stage, or survival between patients with different positive alleles.
Increased frequencies of DRB103-DQA10501-DQB102, DRB113-DQA10103-DQB10603, and DRB115-DQA10102-DQB10602 haplotypes were observed. PSC was negatively associated with DRB104-DQB10302 haplotype.
265/no control (yes, but the number was not cited)
HLADR and DQ
DRB103-DQA10501-DQB102 (i.e., DR3, DQ2) heterozygous genotype was associated with an increased risk of death or liver transplantation. Presence of a DQ6 encoding haplotype (DQB10603 or DQB10602) in DR3, DQ2 negative individuals was associated with a reduced risk of death or liver transplantation.
Associations with the DRB30101-DRB10301-DQA10501-DQB10201 and DRB11301-DQA10103-DQB10603 haplotypes were confirmed. Protective influence of the DRB104-DQB10302 haplotype was reaffirmed. A previously unreported protective haplotype was found: DRB10701-DQB10303.
No increase in the frequency of HLA-B, DRB3, DRB4, or DRB5 alleles was observed. The frequency of HLA-DRB11301 and HLA-DQB106 was significantly increased in PSC patients.
Frequencies of DRB101-DQA10101-DQB10102, DRB116-DQA10102-DQB10502, and DRB104-DQA103-DQB10301 haplotypes were more elevated in PSC patients. DRB107-DQA10201-DQB102 haplotype frequency was significantly decreased in patients.
The strongest association was detected for HLA-B08 and associations with the DRB1 alleles -DRB103, -DRB104, -DRB107, and -DRB11301 also were confirmed.
Frequencies of homozygous HLA DRB10301 (DR3) genes and haplotype A1-B8-DR3 were higher in patients. Frequencies of disease-protective genes DR4 and/or DR15 were lower in the patients.
HLADRB11301-DQB10603 and DRB11501 haplotypes conferred risk for PSC. HLADRB104-DQB103, DRB10701-DQ0303, and DR13:XX (all non-13:01 alleles)-DQB106 demonstrated a protective effect.
HLA: human leukocyte antigen; MHC: major histocompatibility complex; PSC: primary sclerosing cholangitis.